上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2014年
12期
43-46
,共4页
吴晖%刘波%项兆均%秦长征
吳暉%劉波%項兆均%秦長徵
오휘%류파%항조균%진장정
糖代谢异常%糖尿病%心脑血管事件%干预%荟萃分析
糖代謝異常%糖尿病%心腦血管事件%榦預%薈萃分析
당대사이상%당뇨병%심뇌혈관사건%간예%회췌분석
abnormal glucose metabolism%diabetes%cardiovascular and cerebrovascular diseases events%interventions%meta analysis
目的:评价我国干预糖代谢异常人群对心脑血管事件的影响。方法:检索文献,收集我国社区干预糖代谢异常人群对心脑血管事件影响的随机对照试验,评价试验质量,进行荟萃分析。结果:纳入文献9篇,干预组1376例,对照组1025例,平均随访56.25个月。与对照组比较,干预组发生心脑血管事件减少(OR=0.37, P<0.01),全因死亡风险则无减少(OR=0.70,P>0.05)。结论:对糖代谢异常人群进行干预可以减少心脑血管事件的发生,但不能减少全因死亡。
目的:評價我國榦預糖代謝異常人群對心腦血管事件的影響。方法:檢索文獻,收集我國社區榦預糖代謝異常人群對心腦血管事件影響的隨機對照試驗,評價試驗質量,進行薈萃分析。結果:納入文獻9篇,榦預組1376例,對照組1025例,平均隨訪56.25箇月。與對照組比較,榦預組髮生心腦血管事件減少(OR=0.37, P<0.01),全因死亡風險則無減少(OR=0.70,P>0.05)。結論:對糖代謝異常人群進行榦預可以減少心腦血管事件的髮生,但不能減少全因死亡。
목적:평개아국간예당대사이상인군대심뇌혈관사건적영향。방법:검색문헌,수집아국사구간예당대사이상인군대심뇌혈관사건영향적수궤대조시험,평개시험질량,진행회췌분석。결과:납입문헌9편,간예조1376례,대조조1025례,평균수방56.25개월。여대조조비교,간예조발생심뇌혈관사건감소(OR=0.37, P<0.01),전인사망풍험칙무감소(OR=0.70,P>0.05)。결론:대당대사이상인군진행간예가이감소심뇌혈관사건적발생,단불능감소전인사망。
Objective:To evaluate the impact of intervention of the population with abnormal glucose metabolism on the cardiovascular and cerebrovascular diseases (CVD) events in our country. Methods: Randomized controlled trials of community intervention of the population with abnormal glucose metabolism that impacted on the CVD events were collected, and their quality was evaluated and a meta-analysis was conducted through literature search. Results:The intervention group included 1376 cases and the control group of 1025 cases, and on the average, the case of the experience was followed up for 56.25 months in nine lectures. Compared with the control group, the CVD events in the intervention group reduced (OR=0.37, P<0.01). There was no reduction of the risk for all-cause mortality (OR=0.70, P>0.05). Conclusion:The intervention of the population with abnormal glucose metabolism can reduce the CVD events, but can not reduce all-cause mortality.